GUO Xinyi 1,2 , LV Qing 1,2
  • 1. Division of Breast Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
  • 2. Breast Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
LV Qing, Email: lvqing@wchscu.cn
Export PDF Favorites Scan Get Citation

Breast cancer, the most common malignancy in the world, also causes the most death cases of women among malignancies. Breast cancer risk reduction guidelines (version 2023) was updated by National Comprehensive Cancer Network (NCCN). Based on high-level evidences from evidence-based medicine and the latest research progress, the guidelines provided standardized guidance for breast cancer risk assessment and risk reduction strategies for individuals without a history of invasive breast cancer or ductal carcinoma in situ, which has attracted widespread attention from clinicians worldwide. Breast cancer is also the most common malignancy in Chinese women, and the number of newly diagnosed breast cancer cases each year in China ranks first in the world due to the large population, so the breast cancer prevention has become a major public health challenge in China. Aimed to provide reference for breast cancer prevention in China, this article interpreted the guidelines (the new version) based on the characteristics of breast structure in Asian women and the epidemiological characteristics of breast cancer in China.

Citation: GUO Xinyi, LV Qing. Interpretations of the NCCN guidelines for breast cancer risk reduction (version 2023). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(6): 787-804. doi: 10.7507/1007-4848.202303034 Copy

  • Previous Article

    Advances in machine learning in treatment and diagnosis of liver disease
  • Next Article

    Annual progress of transcatheter mitral valve intervention in 2022